Junshi Biosciences Announces Commercialization Partnership with LEO Pharma for Toripalimab in Europe
(HKSE:1877.HK),(Shenzhen:688180.SS), SHANGHAI, Jan. 20, 2025 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, and its wholly-owned subsidiary, TopAlliance Biosciences Inc. (TopAlliance Biosciences), announced a distribution and marketing partnership with LEO Pharma for toripalimab in […]